REVIEW  INNOVATIONS IN GYNECOLOGY AND OBSTETRICS 

Minerva Ginecologica 2019 February;71(1):18-24

DOI: 10.23736/S0026-4784.18.04305-8

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Effectiveness, quality of life and sexual functions in women with anterior compartment prolapse treated by native tissue repair

Marco MONTI ¹ ✉, Michele C. SCHIAVI ¹, Vanessa COLAGIOVANNI ¹, Valentina SCIUGA ¹, Ottavia D'ORIA ¹, Gennaro CERONE ², Maria SCUDO ¹, Marzio A. ZULLO ³, Ludovico MUZII ¹, Pierluigi BENEDETTI PANICI ¹

¹ Department of Gynecological, Obstetric and Urological Sciences, Umberto I Hospital, Sapienza University, Rome, Italy; ² Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy; ³ Department of Surgery-Week Surgery, Campus Biomedico University, Rome, Italy

Anterior compartment defect is the most common pelvic organ prolapse. It is defined as the descent of the bladder into the anterior vaginal wall. The etiology is multifactorial and the main risk factors are vaginal delivery and conditions associated with increased abdominal strain. Aging is significantly associated with the prevalence and severity of pelvic organ prolapse. Treatment may be conservative or surgical according to symptoms, prolapse degree and not forgetting both patient and doctor preferences. The aim of this work is to identify the most efficient surgical treatment of cystocele and its recurrences. There are two different surgical approaches for the treatment of cystocele: traditional repair and mesh repair. Prosthetic treatment gives higher anatomical success rate but traditional anterior repair has less complication demonstrating a lower risk of reoperation. Surgical treatment in general improves both the quality of life (QoL) and the sexual function. We carried out a research on the impact of the anterior defect before and after native tissue surgery on QoL and sexual function. The efficacy and complications of the treatment were also assessed.

KEY WORDS: Pelvic organ prolapse - Urogenital surgical procedures - Therapeutics